The 2004 Annual Meeting (January 14-20, 2004) of OASYS_NEW

Not yet assigned to a slot - 2:00 AM

NF-kB Activation Is Involved in Reperfusion Injury

Qi WN1, Chaiyakit P1, Allen DM1, Cai Y1, Chen LE1, Seaber AV1, and Urbaniak JR2. (1) Surgery, Duke University, PO Box 3093, Durham, NC, USA, (2) Division of Orthopaedic Surgery, Duke University Medical Center, Box 2912, Durham, NC, USA

INTRODUCTION. We hypothesize that ischemia/reperfusion (I/R)-induced nuclear factor-kappa B (NF-kB) activation enhances iNOS expression, resulting in subsequent damage to the microcirculation in reperfused muscle due to excessive NO production from iNOS. This study investigated the effects of pyrrolidine dithiocarbamate (PDTC), a selective NF-kB inhibitor, on microcirculation and iNOS expression in skeletal muscle following I/R.

METHODS. Rats weighing 90-110 g were received PDTC (150mg/kg) or phosphate-buffered saline (PBS, 0.2ml) 15 min prior to reperfusion. The left cremaster muscle of each animal underwent 5 h ischemia and 1.5 h reperfusion. During reperfusion, overall muscle blood flow was measured with laser Doppler flowmetry at 10 min intervals and the expression of iNOS mRNA and protein and NF-kB (p65) protein was determined by using real-time PCR technique and Western blot analysis.

RESULTS. At 10 min of reperfusion, the mean blood flow was only 47±5.6% (mean±SE) of baseline in controls and 79±13% in the PDTC-treated group. There was a significant difference between the two groups (p<0.05). Blood flow gradually increased to close to the baseline level (97±8%) at 50 min of reperfusion and remained at that level throughout the experiment, with a maximum of 102±7.5% at 90 min of reperfusion. In contrast, blood flow in the PDTC-treated group rapidly increased to 98±13% of baseline at 20 min of reperfusion and remained at the level of over baseline throughout the experiment. The highest level of the blood flow was 137±9% of baseline at 80 min of reperfusion. When compared to controls, the blood flow was significantly greater in the PDTC-treated group at 10-30 min and 70-90 min. Expression of iNOS mRNA and protein in controls had 34-fold and 13-fold increase from contralateral normal muscle expression, respectively, but only 14-fold and 1.2-fold increase in the PDTC group, respectively. There was significant difference in both mRNA and protein expression between the two groups. Expression of p65 protein in controls was 22-26% of normal in the cytoplasm and 114-138% in the nucleus. These values were 52-71% and 96-115% in the PDTC group, respectively.

DISCUSSION. Our data have shown that inhibition of NF-kB by PDTC improves microcirculation and reduces upregulated iNOS expression in reperfused skeletal muscle. The results support our hypothesis and indicate that NF-kB activation plays an important role in exaggerate I/R injury. Thus, inhibition of NF-kB activation may be a therapeutic intervention for reperfusion injury.